Progressive Care
Launches New
DischargeRX Program to
Improve Engagement Between
Patients and Hospitals
MIAMI FL -- July
13, 2018 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD),
a personalized
healthcare
services and technology company,
today
announced the launch of its
new
proprietary patient
engagement program, DischargeRX,
designed
to ensure that
hospital
patients are receiving the best transitional care while preserving
vital hospital resources.
According
to a 2017 study published in the Journal
of the American Pharmacists Association, up to 26% of hospital
readmissions are medication-related, creating a much-needed
opportunity for a program to be created that is proactive towards
patient engagement. Through Progressive Care's
wholly owned subsidiaries, DischargeRX
will provide
hospitals with much needed support in preventing unnecessary
and costly
hospital
readmissions. At no
cost to the hospital or patient, the program will provide
access
to a PharmCo representative who will offer medication-related
services throughout the patient's transitional process.
Through
direct interaction between the patient and
PharmCo, the
company is
able to understand
the patient, their healthcare needs, follow-up plans and current
drug regimen. After
the consultation, recommendations may be made to optimize their
prescription therapy through med synchronization and effective
packaging options including
the use of PharmCo's
SmartPack
adherence
solution. The
patient will be given a full overview of
their prescriptions, uses and
best methods for
staying on track with doses.
Once
a patient has received a prescription from their physician, PharmCo
will obtain their prescription(s) directly from the hospital and
fill them, alleviating the
patient of those steps.
After
the prescription is filled,
the patient will receive a home
delivery
of all prescribed medications on
the
same day as
discharge,
and
in some
of the
most effective packaging solutions
available.
PharmCo's
customer
service
staff will
then monitor
the patient's progress and keep them
updated on their
follow-ups with Primary Care and Specialist
physicians.
They will also be
available to provide
mitigation recommendations
for
medication-related
adverse reactions to prevent short-term
medication-related
readmissions, as
well as post-discharge medication reconciliation.
"Our new DischargeRX program hopes to provide even
more patients with Progressive Care's
adherence
packaging, proactive engagement model and pharmacological
expertise," said S. Parikh Mars, CEO of
Progressive Care Inc. "The program's offering also stands to
benefit hospitals, helping them to gain more control over readmission
risk and improve transitional care outcomes, while also providing
significant savings toward preventable adherence-related
healthcare spending."
For
more information about Progressive Care, please visit the
company's website.
Connect and stay
in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care
Inc. (OTCQB:
RXMD),
through its PharmCo, LLC, is a South Florida health services
organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking
Statements
Statements contained herein that are not based upon current
or historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words "anticipate," "believe," "estimate," "upcoming,"
"plan," "target," "intend" and "expect" and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject
to a number of risks, uncertainties, and other
factors that could cause the Company's actual results, performance,
prospects, and opportunities to differ materially from those
expressed in, or implied by, these forward-looking
statements.
Public Relations Contact:
Tory Patterson,
CMW Media
Tory@cmwmedia.com
www.cmwmedia.com
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com